Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 2000 May; 82(9): 1593–1599.
Published online 2000 April 3. doi:  10.1054/bjoc.1999.1181
PMCID: PMC2363407

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity


In a population-based, matched, case–control study from southern Sweden of 571 patients with a first diagnosis of cutaneous malignant melanoma and 913 healthy controls aged 16–80 years, the association between sunbed use and malignant melanoma was evaluated. A total of 250 (44%) cases and 372 (41%) controls reported ever having used sunbeds. A significantly elevated odds ratio for developing malignant melanoma after regular exposure to sunbeds was found, adjusted for hair colour, raised naevi, skin type and number of sunburns (odds ratio (OR) 1.8, 95% confidence interval (CI) 1.2–2.7). A dose–response relationship between total number of sunbed uses and melanoma risk was only found up to the level of 250 times. The OR was higher in individuals younger than age 36 years (adjusted OR 8.1, 95% CI 1.3–49.5 for regular vs never use). The association seemed to be true only for subjects with black/dark brown or light brown hair and among females. Lesions of the extremities showed the strongest association of increased risk with sunbed use. An increased risk was related to commercial exposure and to exposure during the winter. The results substantiate the hypothesis that exposure to sunbeds might increase the risk of developing malignant melanoma. © 2000 Cancer Research Campaign

Keywords: melanoma, ultraviolet radiation, sunbeds, risk

Full Text

The Full Text of this article is available as a PDF (91K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Autier P, Joarlette M, Lejeune F, Liénard D, André J, Achten G. Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium. Melanoma Res. 1991 Apr-May;1(1):69–74. [PubMed]
  • Autier P, Doré JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini JP, Lienard D, Liabeuf A, Joarlette M, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer. 1994 Sep 15;58(6):809–813. [PubMed]
  • Boldeman C, Beitner H, Jansson B, Nilsson B, Ullén H. Sunbed use in relation to phenotype, erythema, sunscreen use and skin diseases. A questionnaire survey among Swedish adolescents. Br J Dermatol. 1996 Nov;135(5):712–716. [PubMed]
  • Boldeman C, Jansson B, Nilsson B, Ullén H. Sunbed use in Swedish urban adolescents related to behavioral characteristics. Prev Med. 1997 Jan-Feb;26(1):114–119. [PubMed]
  • Chen YT, Dubrow R, Zheng T, Barnhill RL, Fine J, Berwick M. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol. 1998 Oct;27(5):758–765. [PubMed]
  • Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977 May;105(5):488–495. [PubMed]
  • Diffey BL, Farr PM. Tanning with UVB or UVA: an appraisal of risks. J Photochem Photobiol B. 1991 Jan;8(2):219–223. [PubMed]
  • Gallagher RP, Elwood JM, Hill GB. Risk factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Recent Results Cancer Res. 1986;102:38–55. [PubMed]
  • Holman CD, Armstrong BK, Heenan PJ, Blackwell JB, Cumming FJ, English DR, Holland S, Kelsall GR, Matz LR, Rouse IL, et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res. 1986;102:18–37. [PubMed]
  • Jones SK, Moseley H, Mackie RM. UVA-induced melanocytic lesions. Br J Dermatol. 1987 Jul;117(1):111–115. [PubMed]
  • Lillquist PP, Baptiste MS, Witzigman MA, Nasca PC. A population-based survey of sun lamp and tanning parlor use in New York State, 1990. J Am Acad Dermatol. 1994 Sep;31(3 Pt 1):510–512. [PubMed]
  • MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989 Aug 26;2(8661):487–490. [PubMed]
  • Miller SA, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem Photobiol. 1998 Jul;68(1):63–70. [PubMed]
  • Moan J, Dahlback A, Setlow RB. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol. 1999 Aug;70(2):243–247. [PubMed]
  • Osterlind A, Engholm G, Jensen OM. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site. APMIS. 1988 Nov;96(11):953–963. [PubMed]
  • Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer. 1988 Sep 15;42(3):319–324. [PubMed]
  • Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6666–6670. [PubMed]
  • Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med. 1997 Apr 10;336(15):1041–1045. [PubMed]
  • Swerdlow AJ, English JS, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, Hole DJ. Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ. 1988 Sep 10;297(6649):647–650. [PMC free article] [PubMed]
  • Thörn M, Bergström R, Adami HO, Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol. 1990 Dec;132(6):1066–1077. [PubMed]
  • Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol. 1990 Feb;131(2):232–243. [PubMed]
  • Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N, Brandt L, Jönsson PE, Möller T. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol. 1994 Oct 15;140(8):691–699. [PubMed]
  • Westerdahl J, Anderson H, Olsson H, Ingvar C. Reproducibility of a self-administered questionnaire for assessment of melanoma risk. Int J Epidemiol. 1996 Apr;25(2):245–251. [PubMed]
  • Williams HC, Salisbury J, Brett J, du Vivier A. Sunbed lentigines. Br Med J (Clin Res Ed) 1988 Apr 16;296(6629):1097–1097. [PMC free article] [PubMed]
  • Wolff K. Should PUVA be abandoned? N Engl J Med. 1997 Apr 10;336(15):1090–1091. [PubMed]
  • Wright A, Hart G, Kernohan L. Dangers of sunbeds are greater in the commercial sector. BMJ. 1997 Apr 26;314(7089):1280–1281. [PMC free article] [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK